Pulseless Electrical Activity (PEA) and Patient Survival

Understanding PEA

• PEA is defined as cardiac electrical activity without a detectable pulse or blood pressure, representing a critical cardiac arrest state requiring immediate intervention with a poor but not zero chance of survival, according to the American Heart Association 1, 2
• PEA is distinct from other cardiac arrest rhythms like ventricular fibrillation (VF), ventricular tachycardia (VT), and asystole, as stated by the American College of Cardiology 3

Management of PEA

• The American Heart Association recommends beginning high-quality CPR with minimal interruptions in chest compressions, establishing vascular access, and administering epinephrine 0.01 mg/kg every 3-5 minutes while CPR continues 1, 4, 5, 3
• Consideration and treatment of potentially reversible causes, such as hypovolemia, hypoxia, and hydrogen ion (acidosis), are crucial, as suggested by the American College of Cardiology 4, 6, 2
• For suspected pulmonary embolism as the cause of PEA, thrombolysis, surgical embolectomy, or mechanical embolectomy are reasonable emergency treatment options, according to the American Heart Association 7, 6
• Early administration of systemic thrombolysis is associated with improved outcomes compared to use after failure of conventional ACLS, as stated by the American College of Cardiology 6
• Higher doses of epinephrine may be indicated for specific causes like β-blocker or calcium channel blocker overdose, with hemodynamic monitoring guiding dosing, as recommended by the American Heart Association 3
• Comprehensive post-cardiac arrest care, including consideration of targeted temperature management and addressing the underlying cause, should be initiated if ROSC is achieved, according to the American College of Cardiology 2

Important Considerations

• PEA is often caused by reversible conditions, including hypovolemia, hypoxia, and hydrogen ion (acidosis), and prompt treatment of these underlying causes is essential, as stated by the American Heart Association 4, 2
• The presence of PEA should prompt an immediate search for and treatment of underlying causes, according to the American College of Cardiology 2
• Vasopressors may improve ROSC and short-term survival, though evidence for improved long-term outcomes is limited, as suggested by the American Heart Association 4, 3

Management of Pulseless Electrical Activity

Introduction to PEA Management

• The American Heart Association recommends epinephrine as the primary vasopressor for PEA, with no recommendation for norepinephrine in this setting 8

Vasopressor Use in Cardiac Arrest

• Epinephrine is the primary vasopressor recommended for all forms of cardiac arrest, including PEA 8
• While vasopressors may improve return of spontaneous circulation (ROSC) and short-term survival, there is insufficient evidence that they improve survival to discharge or neurological outcomes 8, 9
• There is no specific recommendation for norepinephrine (Levophed) use in the PEA cardiac arrest algorithm 8, 10

Special Considerations in PEA

• For hypotension that is refractory to volume replacement and epinephrine injections (not in cardiac arrest), dopamine can be considered as a vasopressor infusion 11, 12
• In anaphylaxis-related cardiac arrest with PEA, high-dose epinephrine administration is recommended, with potential consideration of higher subsequent dosages for unresponsive PEA 11, 12
• Prolonged resuscitation efforts are encouraged in PEA, as they are more likely to be successful, particularly when the patient is young with a healthy cardiovascular system 12

Avoiding Common Pitfalls in PEA Management

• Premature termination of resuscitation efforts in PEA, when continued efforts may be beneficial, should be avoided 12
• Atropine and transcutaneous pacing should be considered if asystole and/or PEA are present, particularly in anaphylaxis-related cardiac arrest 11, 12

Pulseless Electrical Activity with Fixed and Dilated Pupils

Critical Context and Diagnostic Considerations

• The presence of fixed and dilated pupils during cardiopulmonary resuscitation (CPR) should not be considered an absolute contraindication to resuscitation or a definitive sign of irreversible brain injury, as current evidence demonstrates that fixed, dilated pupils are frequently seen during CPR, particularly after epinephrine administration, and patients have achieved favorable neurological outcomes despite these findings 13, 14
• Epinephrine causes pupillary dilation, and fixed and dilated pupils are an expected pharmacologic effect during active resuscitation with epinephrine, not necessarily a sign of brain death 13, 14
• The absence of brainstem reflexes with fixed, dilated pupils before cannulation was previously considered a contraindication to advanced support like ECMO, but this has been reconsidered given documented favorable outcomes 13, 14

Diagnostic Confirmation and Management Approach

• Pulse assessment is unreliable, and physical examination findings are often interpreted incorrectly during emergent evaluation, highlighting the need for alternative diagnostic methods 15, 16
• Bedside cardiac ultrasound is recommended for accurate diagnosis of true PEA arrest, evaluation for reversible causes, and differentiation of pseudo-PEA states with actual wall motion 15, 16
• Aggressively searching for and treating reversible causes, including hypovolemia, hypoxia, hydrogen ion (acidosis), hypo/hyperkalemia, hypothermia, toxins, tamponade, tension pneumothorax, thrombosis (coronary/pulmonary), and trauma, is crucial in managing PEA 15, 16, 17

Prognostic Considerations and Advanced Care

• The American Heart Association recommends considering thrombolysis, surgical embolectomy, or mechanical embolectomy as reasonable emergency treatment options for suspected pulmonary embolism, with early systemic thrombolysis associated with improved outcomes 17
• Higher epinephrine doses may be indicated for specific toxicologic causes, and bedside cardiac ultrasound can help identify reversible causes and confirm true PEA versus pseudo-PEA with cardiac motion 15, 16

PEA Arrest Etiologies and Management

Clinical Approach to Diagnosis

• The American Heart Association emphasizes that PEA is often caused by reversible conditions that can be successfully treated if identified and corrected promptly, and during each 2-minute CPR cycle, providers should systematically recall the "H's and T's" 18
• Providers should recall the "H's and T's": hypovolemia, hypoxia, hydrogen ion (acidosis), hypo/hyperkalemia, hypothermia, toxins, tamponade, tension pneumothorax, thrombosis (coronary or pulmonary), and trauma, to identify reversible causes 19, 20, 18

Diagnostic Tools

• Bedside cardiac ultrasound should be performed immediately in PEA to accurately diagnose true PEA arrest, evaluate for reversible causes, and differentiate pseudo-PEA states with wall motion 19, 20
• The examination should not interrupt chest compressions for more than 10 seconds, as physical examination findings, including pulse assessment, are frequently interpreted incorrectly during cardiac arrest 19

Critical Management Implications

• Given the high frequency of hypoxia as a cause, placement of an advanced airway is theoretically more important in PEA than in VF/pulseless VT arrests, according to the American Heart Association 18
• For tension pneumothorax, immediate needle decompression should be performed if clinically suspected, as recommended by the American Heart Association 18
• For hypovolemia/sepsis, empirical IV/IO crystalloid administration is potentially beneficial, as stated by the American Heart Association 18

Audible Heart Sounds in Pulseless Electrical Activity Do Not Indicate Return of Circulation

Definition and Physiological Basis

• Audible heart sounds can be heard during pulseless electrical activity because organized electrical activity on the monitor can generate mechanical vibrations, yet this activity is insufficient to produce a palpable pulse or measurable arterial pressure. 21
• Pulseless electrical activity is defined as organized cardiac electrical activity on the monitor without a detectable pulse or measurable blood pressure, reflecting electromechanical dissociation. 22

Clinical Assessment

• The absence of a palpable pulse (carotid or femoral) remains the defining feature of cardiac arrest, even when heart sounds are audible or electrical activity is present. 21

Prognostic Implications

• Development of secondary ventricular fibrillation/ventricular tachycardia during resuscitation from PEA or asystole is associated with lower rates of return of spontaneous circulation and reduced survival compared with an initial shockable rhythm. 23

Management of Pulseless Electrical Activity (PEA)

Definition and Diagnostic Criteria

Clinical Assessment

Prognosis

Resuscitation Strategy

Reversible Causes – Specific Interventions

Ultrasound Utilization

Decision‑Making on Termination of Resuscitation

Guideline Recommendations on Electrical Activity and Defibrillation in Pulseless Electrical Activity

Electrophysiological Characteristics of PEA

• Organized electrical activity persists on the cardiac monitor, displaying coordinated depolarization waves despite the absence of effective myocardial contraction, confirming electromechanical dissociation in PEA. 28

Defibrillation Guidance for PEA

• Pulseless Electrical Activity is classified as a non‑shockable rhythm; therefore, defibrillation is not indicated and should be omitted during resuscitation efforts for PEA. [29][30]

Evidence‑Based Management of Prolonged PEA Cardiac Arrest

1. Epinephrine Dosing in Cardiac Arrest

• The American Heart Association (AHA) states that there is no established maximum cumulative epinephrine dose; the standard protocol of 1 mg IV/IO every 3–5 minutes should be continued throughout resuscitation, and a total of 6 mg administered over 45 minutes is fully consistent with guideline recommendations. Class I, Level B evidence. [31][32]33

• High‑dose epinephrine (0.1–0.2 mg/kg, ≈7–14 mg in a 70‑kg adult) has been studied repeatedly and fails to improve survival to discharge or neurological outcome compared with the standard 1 mg dose; it may even cause harm, especially in asphyxial arrests. Class III: No Benefit. [34][32]33

• The 2010 AHA guidelines and subsequent updates recommend against high‑dose epinephrine except in rare situations such as beta‑blocker or calcium‑channel‑blocker overdose. Class III. [34][32]

2. Why Epinephrine Does Not Increase Heart Rate in PEA

• PEA is defined as organized cardiac electrical activity without a palpable pulse or measurable arterial pressure; the observed rhythm already reflects coordinated depolarization that cannot generate effective mechanical contraction. 31

• The primary physiologic effect of epinephrine in cardiac arrest is α‑adrenergic peripheral vasoconstriction, which raises coronary and cerebral perfusion pressures during chest compressions; it does not provide a chronotropic effect on the electrical rate. [32][33]

• A wide‑complex PEA rhythm in this context suggests a severe underlying pathology, most commonly an acute myocardial infarction causing profound pump failure. 35

3. End‑Tidal CO₂ (EtCO₂) as a Real‑Time Marker of CPR Quality

• EtCO₂ rises proportionally with more vigorous chest compressions because effective compressions increase cardiac output and pulmonary blood flow, delivering more CO₂ from peripheral tissues to the lungs. Class I, Level B. 31

• PetCO₂ < 10 mmHg indicates inadequate CPR quality and should trigger immediate improvement of compression technique. Class I, Level C‑LD. 31

• PetCO₂ ≥ 20 mmHg during CPR is associated with better cardiac output and coronary perfusion; sustained values ≥ 40 mmHg are a reliable indicator of return of spontaneous circulation (ROSC) and should prompt an immediate pulse check. Class I, Level B. 31

• An initial EtCO₂ of ~32 mmHg reflects reasonably effective CPR, but variability among compressors underscores the importance of rotating the compressor every 2 minutes to prevent fatigue‑related decline in quality. Class I, Level C‑LD. 31

4. Prioritization of Interventions for PEA (Presumed Massive MI)

4.1 High‑Quality Chest Compressions (Top Priority)

• Chest compressions are the only intervention proven to maintain coronary and cerebral perfusion during cardiac arrest. Class I, Level A. [31][33]

• Recommended compression metrics: depth ≥ 5 cm (2 inches), rate 100–120 compressions/min, full recoil, interruptions < 10 seconds, and compressor rotation every 2 minutes. Class I, Level C‑LD. 31

4.2 Epinephrine (Second Priority)

• 1 mg IV/IO every 3–5 minutes improves ROSC and short‑term survival; the effect on long‑term neurological outcome remains uncertain. Class I, Level B‑R. [32][33]

• The PARAMEDIC‑2 trial demonstrated that epinephrine increased ROSC (36.3 % vs 11.7 %) and 30‑day survival (3.2 % vs 2.4 %) in out‑of‑hospital cardiac arrest, supporting its continued use despite ongoing debate about neurological benefit. Class I, Level A. [32][33]

• In non‑shockable rhythms (PEA), earlier epinephrine administration is associated with higher ROSC rates, although overall survival benefits are less consistent. Class IIa, Level B‑R. 33

4.3 Fluid Administration (Third Priority in This Scenario)

• Empiric crystalloid infusion (e.g., 1.5 L) is reasonable to address potential hypovolemia, one of the “H” reversible causes, and should be considered during each 2‑minute CPR cycle. Class IIb, Level C‑LD. 31

• In pure cardiogenic shock from massive MI, fluids provide limited benefit compared with hypovolemic or septic etiologies.

4.4 Advanced Airway Management (Fourth Priority)

• Placement of an advanced airway has not been shown to improve survival to discharge and must never delay chest compressions or other critical interventions. Class III, Level B‑R. [31][32]

• After airway placement, deliver 1 breath every 6 seconds (8–10 breaths/min) while maintaining continuous compressions at ≥ 100 /min without pauses for ventilation. Class I, Level C‑LD. 31

• Waveform capnography should be used to confirm tube placement and to monitor CPR quality via EtCO₂ trends. Class I, Level C‑LD. 31

5. Summary of Key Quantitative Benchmarks

Management of Non‑Shockable Cardiac Arrest Rhythms (PEA and Asystole)

1. Definition and Prognostic Implications

• Both pulseless electrical activity (PEA) and asystole are classified as non‑shockable cardiac arrest rhythms; PEA is identified by organized electrical activity on the monitor without a palpable pulse, whereas asystole shows a flat line or minimal activity (< 5 bpm). American Heart Association (AHA) guidelines. 36
• Asystole represents a complete absence of ventricular electrical activity, is often the terminal rhythm after prolonged ventricular fibrillation or PEA, and carries a markedly worse prognosis than PEA. AHA guidelines. 37

2. Core Resuscitation Strategy – Systematic Evaluation of Reversible Causes

• During every 2‑minute CPR cycle, clinicians should systematically assess the “H’s and T’s” (hypovolemia, hypoxia, hydrogen ion (acidosis), hypo/hyper‑kalemia, hypothermia, toxins, tamponade, tension pneumothorax, thrombosis, trauma); this evaluation is the cornerstone of PEA/asystole management and the primary determinant of survival. AHA guidelines. 37

2.1. The “H” Causes

2.2. The “T” Causes

3. Diagnostic Ultrasound as a Rapid Differentiator

• Bedside cardiac ultrasound performed within ≤10 seconds of a pulse check can identify reversible anatomic causes (e.g., tamponade, tension pneumothorax) and distinguish true PEA (no cardiac wall motion) from pseudo‑PEA (residual contractility). AHA guidelines. 37

4. High‑Quality Chest Compressions and Pharmacologic Support

• Compression Quality – Deliver compressions ≥5 cm depth at a rate of 100–120 compressions/min, ensure full chest recoil, and limit interruptions to <10 seconds. AHA guidelines. 38
• Vascular Access & Epinephrine – Establish IV or IO access promptly; administer epinephrine 1 mg as soon as possible and repeat every 3–5 minutes during resuscitation. AHA guidelines. 38
• Team Fatigue Management – Rotate the person performing compressions every 2 minutes to prevent fatigue‑related decline in compression quality. AHA guidelines. 38

5. Pharmacologic Adjustments Specific to Rhythm Type

• Atropine – Routine use of atropine has been removed from the cardiac arrest algorithm for PEA and asystole because it does not provide therapeutic benefit in these rhythms. AHA guidelines. 37

All facts above are derived from peer‑reviewed sources cited in the original article and reflect the recommendations of the American Heart Association’s cardiac arrest guidelines.